1Prud'homme GJ. Pathobinlogy of transforming growth factor beta in cancer,fibrosis and immunologic disease,and therapeutic considerations [J]. Lab Invest,2007 ; 87 (11) : 1077-91.
2Rippmann JF, Pfizenmaier K, Mattes R, et al. Fusion of the tissue factor extracellular domain to a tumor stroma specific single-chain fragment variable antibody results in an antigen-specific coagulation-promoting molecule[J]. Biochemistrv,2000;349(3) :805-12.
3Cohen S J, Alpaugh RK, Palazzo I,et al. Fibroblast activation protein and its relationship to clinical outcome in pancreatic Aden carcinoma [J]. Pancreas ,2008 ;37 ( 2 ) : 154-8.
4Goscinski MA, Suo Z, Florenes VA, et al. FAP-alpha and uPA shoe different expression patterns in premalignant and malignant esophageal lesions [ J ]. Oncology ,2003 ;65 (4) : 363-70.
5Ghersi G,Zhao Q,Salamone M ,et al. The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices [J]. Cancer Res,2006 ;66 ( 127 ) :4652-61.
6Sporn MB, Pwberts AB, Wakefield LM, et al. Transforming growth factorβ: Biological function and chemical structure[J]. Science, 1986: 233 (4763) :532-4.
7Massague J, TGFβ signal transduction [J]. Annu Rev Biochem, 1998 ;67 : 753-91.
8Briskin K B, Fady C, Miokel RA ,et al. Inhibition of head anti neeksquamous cell careinoma cell lines by transforming growth factor beta [J]. Laryngol Head Neck Surg, 1995 ; 112 ( 6 ) : 728-34.
9Cui W,Fowlis DJ,Sheila B,et al. TGF-β1 inhibits tile formation of benign skin tumors,but enhances progression to invasive spindle carcinomas in transgenle mice [J]. Cell, 1996 ;86 (6) : 531 -42.
10Otani N, Tsukamoto T, Masumori N, et al. Influence of growth factor in vitro invasiveness and type N collagenolysis of human renal cell carcinoma[J]. J Urol,1994 ; 151 ( 1 ) :223-6.
